---
figid: PMC8777575__12672_2021_439_Fig2_HTML
figtitle: 'Gold complex auranofin: new perspectives for cancer therapy'
organisms:
- Homo sapiens
- Mus musculus
- Mycobacterium tuberculosis
- Anemone sylvestris
pmcid: PMC8777575
filename: 12672_2021_439_Fig2_HTML.jpg
figlink: /pmc/articles/PMC8777575/figure/Fig2/
number: F2
caption: Auranofin (AUR) inhibits the anti-oxidant enzymes thioredoxin reductase 1
  (TrxR1) and 2 (TrxR2) resulting in an increase in the level of intracellular reactive
  oxygen species (ROS), mitochondrial permeability, and DNA damage. A AUR inhibits
  glycolysis resulting in reduced ATP levels and inhibition of the function of drug
  transporter, ABCG2, preventing development of drug resistance. B AUR-mediated ROS
  production causes ER stress and PERK activation, leading to cell death. C AUR inhibits
  the function of deubiquitinases enzymes (DUBs) in protein homeostasis and induction
  of tumor growth. D Increased ROS induced by AUR causes decreased membrane potential
  in the mitochondrial membrane, resulting in a decrease in anti-apoptotic proteins,
  caspase-dependent cell death, and translocation of apoptosis-inducing factor (AIF)
  into the nucleus to trigger caspase-independent cell death. E AUR inhibits the IKK-β
  signaling pathway, which normally induces FOXO3 tumor suppressor degradation. The
  inhibition of IKK-β by AUR allows the nuclear translocation of FOXO3, activating
  proapoptotic proteins, resulting in cell death. F AUR inhibits the PI3K/AKT/mTOR
  pathway, resulting in the inhibition of pro-angiogenic factors like HIF-1α, preventing
  tumorigenesis. G AUR activates ASK1 leading to p38-mediated cell death. H AUR promotes
  the conversion of H2O2 to ˑOH via the Fenton reaction, resulting in the induction
  of cell death
papertitle: 'The gold complex auranofin: new perspectives for cancer therapy.'
reftext: Farah H. Abdalbari, et al. Discov Oncol. 2021 Dec;12:42.
year: '2021'
doi: 10.1007/s12672-021-00439-0
journal_title: Discover. Oncology
journal_nlm_ta: Discov Oncol
publisher_name: Springer US
keywords: Auranofin | Cancer | Thioredoxin reductase | Immunogenic cell death | Cisplatin
automl_pathway: 0.9504946
figid_alias: PMC8777575__F2
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC8777575__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8777575__12672_2021_439_Fig2_HTML.html
  '@type': Dataset
  description: Auranofin (AUR) inhibits the anti-oxidant enzymes thioredoxin reductase
    1 (TrxR1) and 2 (TrxR2) resulting in an increase in the level of intracellular
    reactive oxygen species (ROS), mitochondrial permeability, and DNA damage. A AUR
    inhibits glycolysis resulting in reduced ATP levels and inhibition of the function
    of drug transporter, ABCG2, preventing development of drug resistance. B AUR-mediated
    ROS production causes ER stress and PERK activation, leading to cell death. C
    AUR inhibits the function of deubiquitinases enzymes (DUBs) in protein homeostasis
    and induction of tumor growth. D Increased ROS induced by AUR causes decreased
    membrane potential in the mitochondrial membrane, resulting in a decrease in anti-apoptotic
    proteins, caspase-dependent cell death, and translocation of apoptosis-inducing
    factor (AIF) into the nucleus to trigger caspase-independent cell death. E AUR
    inhibits the IKK-β signaling pathway, which normally induces FOXO3 tumor suppressor
    degradation. The inhibition of IKK-β by AUR allows the nuclear translocation of
    FOXO3, activating proapoptotic proteins, resulting in cell death. F AUR inhibits
    the PI3K/AKT/mTOR pathway, resulting in the inhibition of pro-angiogenic factors
    like HIF-1α, preventing tumorigenesis. G AUR activates ASK1 leading to p38-mediated
    cell death. H AUR promotes the conversion of H2O2 to ˑOH via the Fenton reaction,
    resulting in the induction of cell death
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Abcg2
  - Wdtc1
  - Mdga2
  - Eif2ak3
  - Lamp1
  - Eif2a
  - Eif2s1
  - Bax
  - Nkx3-1
  - Bak1
  - Txnrd1
  - Bcl2
  - Bcl2l1
  - Mcl1
  - Txnrd2
  - Aifm1
  - Casp7
  - Casp3
  - Parp1
  - Ikbkb
  - Foxo3
  - Pik3r1
  - Akt1
  - Mtor
  - Bcl2l11
  - Hif1a
  - Map3k5
  - Crk
  - Grap2
  - Syp
  - Mapk14
  - Ahsa1
  - oh
  - ATP8A2
  - ABCG2
  - WDTC1
  - EIF2AK3
  - EIF2A
  - EIF2S1
  - BAX
  - BAK1
  - TXNRD1
  - BCL2
  - MCL1
  - TXNRD2
  - AIFM1
  - CASP3
  - CASP7
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - PARP1
  - COL11A2
  - PARP2
  - PARP3
  - PARP4
  - PARP6
  - PARP8
  - PARP9
  - PARP10
  - PARP11
  - PARP12
  - PARP14
  - PARP15
  - PARP16
  - TNKS
  - TNKS2
  - TIPARP
  - IKBKB
  - FOXO3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - BCL2L11
  - HIF1A
  - MAP3K5
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
---
